Thursday, December 07, 2006 6:00:00 AM PDT | VentureDeal Staff
DANVERS, MA -- Cell Signaling Technology, Inc. announced that it had signed an agreement with Bristol-Myers Squibb to perform a phosphoproteomic research for the drug giant.While terms of the agreement were not disclosed, the company indicated that the research to be done included its PhosphoScan technology to provide Bristol-Myers with cellular phospho-profiles of a small molecule kinase inhibitor.Cell Signaling Technology has a large product line of phospho-related testing systems and supplies.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
© VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.